Celgene Corp. sent a letter last week to healthcare providers warning that their blood thinner Innohep may increase the risk of death in elderly patients with kidney problems, recommending that…
Tag Archives: Innohep
The FDA has issued an early communication about an on-going safety review into potential side effects of Innohep, a low-molecular weight heparin. The agency has asked the drug maker to…
Side effects of Innohep, a low molecular weight heparin, have been linked to an increased risk of death when used to treat deep vein thrombosis (DVT) or pulmonary embolism among…
More Top Stories
Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.
A $479 million Philips CPAP class action settlement agreement will resolve claims of economic loss filed by users of the recalled devices.